• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Pieris Pharmaceuticals Inc (NQ: PIRS )

    16.37 -0.09 (-0.55%)
    Streaming Delayed Price Updated: 9:30 AM EDT, Aug 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 139
    Open 16.37
    Bid (Size) 16.23 (1)
    Ask (Size) 17.12 (2)
    Prev. Close 16.46
    Today's Range 16.37 - 16.37
    52wk Range 6.200 - 41.78
    Shares Outstanding 98,935,025
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    PIERIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pieris Pharmaceuticals, Inc. - PIRS
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Crude Oil Gains 1%; AT&T Shares Rise After Q2 Earnings
    Via Benzinga
    Exposures Fossil Fuels

    Performance

    YTD
    +9.90%
    +9.90%
    1 Month
    +117.98%
    +117.98%
    3 Month
    +46.95%
    +46.95%
    6 Month
    +19.80%
    +19.80%
    1 Year
    -7.16%
    -7.16%

    More News

    Read More
    ALLR Stock Alert: Allarity Therapeutics Pushes Shareholders to Back Reverse Split
    Via InvestorPlace
    Dow Tumbles 300 Points; Tesla Shares Plunge After Q2 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Looking Into Pieris Pharmaceuticals's Recent Short Interest
    Via Benzinga
    Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why Is Pieris Pharmaceuticals (PIRS) Stock Up 77% Today?
    Via InvestorPlace
    PIRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement
    Via ACCESSWIRE
    PIRS Stock Earnings: Pieris Pharmaceuticals Reported Results for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split
    Via ACCESSWIRE
    Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why Affirm Holdings Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    Why Splunk Are Trading Higher By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.